Copyright Reports & Markets. All rights reserved.

(Post-pandemic Era)-Global The Equine Pharmaceuticals and Supplements Market Segment Research Report 2021

Request for Sample of this report
Buy now

Table of Contents

    Global The Equine Pharmaceuticals and Supplements Market Segment Research Report 2021

      1. Research Scope

        2. Market Overview

        • 2.1 Product Introduction, Application, Picture
        • 2.2 Global The Equine Pharmaceuticals and Supplements Market by Value
          • 2.2.1 Global The Equine Pharmaceuticals and Supplements Revenue by Type
          • 2.2.2 Global The Equine Pharmaceuticals and Supplements Market by Value (%)
        • 2.3 Global The Equine Pharmaceuticals and Supplements Market by Production
          • 2.3.1 Global The Equine Pharmaceuticals and Supplements Production by Type
          • 2.3.2 Global The Equine Pharmaceuticals and Supplements Market by Production (%)

        3. The Major Driver of The Equine Pharmaceuticals and Supplements Industry

        • 3.1 Historical & Forecast Global The Equine Pharmaceuticals and Supplements Demand
        • 3.2 Largest Application for The Equine Pharmaceuticals and Supplements (2017-2027)
        • 3.3 The Major Downstream Company in China Market 2021

        4. Global and Regional The Equine Pharmaceuticals and Supplements Market

        • 4.1 Regional Market Size in Terms of Production & Demand (2021)
        • 4.2 Regional Market Share in Terms of Revenue (2019-2027)
        • 4.3 Concentration Ratio (CR5& CR10) of The Equine Pharmaceuticals and Supplements Market
        • 4.4 Mergers & Acquisitions, Expansion Plans

        5. US The Equine Pharmaceuticals and Supplements Production, Demand (2017-2027)

        • 5.1 Current and Estimated Production Breakdown by Type
        • 5.2 Current and Estimated Demand Breakdown by Type
        • 5.3 Current and Estimated Demand Breakdown by Application
        • 5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
        • 5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

        6. Europe The Equine Pharmaceuticals and Supplements Production, Demand (2017-2027)

        • 6.1 Current and Estimated Production Breakdown by Type
        • 6.2 Current and Estimated Demand Breakdown by Type
        • 6.3 Current and Estimated Demand Breakdown by Application
        • 6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
        • 6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

        7. China The Equine Pharmaceuticals and Supplements Production, Demand (2017-2027)

        • 7.1 Current and Estimated Production Breakdown by Type
        • 7.2 Current and Estimated Demand Breakdown by Type
        • 7.3 Current and Estimated Demand Breakdown by Application
        • 7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
        • 7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

        8. Japan The Equine Pharmaceuticals and Supplements Production, Demand (2017-2027)

        • 8.1 Current and Estimated Production Breakdown by Type
        • 8.2 Current and Estimated Demand Breakdown by Type
        • 8.3 Current and Estimated Demand Breakdown by Application
        • 8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
        • 8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

        9. India The Equine Pharmaceuticals and Supplements Production, Demand (2017-2027)

        • 9.1 Current and Estimated Production Breakdown by Type
        • 9.2 Current and Estimated Demand Breakdown by Type
        • 9.3 Current and Estimated Demand Breakdown by Application
        • 9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
        • 9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

        10. Korea The Equine Pharmaceuticals and Supplements Production, Demand (2017-2027)

        • 10.1 Current and Estimated Production Breakdown by Type
        • 10.2 Current and Estimated Demand Breakdown by Type
        • 10.3 Current and Estimated Demand Breakdown by Application
        • 10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
        • 10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

        11. Southeast Asia The Equine Pharmaceuticals and Supplements Production, Demand (2017-2027)

        • 11.1 Current and Estimated Production Breakdown by Type
        • 11.2 Current and Estimated Demand Breakdown by Type
        • 11.3 Current and Estimated Demand Breakdown by Application
        • 11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
        • 11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

        12. Global The Equine Pharmaceuticals and Supplements Average Price Trend

        • 12.1 Market Price for Each Type of The Equine Pharmaceuticals and Supplements in US (2017-2021)
        • 12.2 Market Price for Each Type of The Equine Pharmaceuticals and Supplements in Europe (2017-2021)
        • 12.3 Market Price for Each Type of The Equine Pharmaceuticals and Supplements in China (2017-2021)
        • 12.4 Market Price for Each Type of The Equine Pharmaceuticals and Supplements in Japan (2017-2021)
        • 12.5 Market Price for Each Type of The Equine Pharmaceuticals and Supplements in India (2017-2021)
        • 12.6 Market Price for Each Type of The Equine Pharmaceuticals and Supplements in Korea (2017-2021)
        • 12.7 Market Price for Each Type of The Equine Pharmaceuticals and Supplements in Southeast Asia (2017-2021)

        13. Industrial Chain (Impact of COVID-19)

        • 13.1 The Equine Pharmaceuticals and Supplements Industrial Chain Analysis
        • 13.2 Downstream
        • 13.3 Impact of COVID-19
        • 13.4 Technology Trends of The Equine Pharmaceuticals and Supplements

        14. The Equine Pharmaceuticals and Supplements Competitive Landscape

        • 14.1 Boehringer Ingelheim
          • 14.1.1 Boehringer Ingelheim Company Profiles
          • 14.1.2 Boehringer Ingelheim Product Introduction
          • 14.1.3 Boehringer Ingelheim The Equine Pharmaceuticals and Supplements Sales, Revenue (2017-2021)
          • 14.1.4 Strategic initiatives
        • 14.2 Virbac
          • 14.2.1 Virbac Company Profiles
          • 14.2.2 Virbac Product Introduction
          • 14.2.3 Virbac The Equine Pharmaceuticals and Supplements Sales, Revenue (2017-2021)
          • 14.2.4 Strategic initiatives
        • 14.3 Bayer Animal Health
          • 14.3.1 Bayer Animal Health Company Profiles
          • 14.3.2 Bayer Animal Health Product Introduction
          • 14.3.3 Bayer Animal Health The Equine Pharmaceuticals and Supplements Sales, Revenue (2017-2021)
          • 14.3.4 Strategic initiatives
        • 14.4 Merck Animal Health
          • 14.4.1 Merck Animal Health Company Profiles
          • 14.4.2 Merck Animal Health Product Introduction
          • 14.4.3 Merck Animal Health The Equine Pharmaceuticals and Supplements Sales, Revenue (2017-2021)
          • 14.4.4 Strategic initiatives
        • 14.5 CEVA
          • 14.5.1 CEVA Company Profiles
          • 14.5.2 CEVA Product Introduction
          • 14.5.3 CEVA The Equine Pharmaceuticals and Supplements Sales, Revenue (2017-2021)
          • 14.5.4 Strategic initiatives
        • 14.6 Zoetis
          • 14.6.1 Zoetis Company Profiles
          • 14.6.2 Zoetis Product Introduction
          • 14.6.3 Zoetis The Equine Pharmaceuticals and Supplements Sales, Revenue (2017-2021)
          • 14.6.4 Strategic initiatives
        • 14.7 Kyoritsu Seiyaku
          • 14.7.1 Kyoritsu Seiyaku Company Profiles
          • 14.7.2 Kyoritsu Seiyaku Product Introduction
          • 14.7.3 Kyoritsu Seiyaku The Equine Pharmaceuticals and Supplements Sales, Revenue (2017-2021)
          • 14.7.4 Strategic initiatives
        • 14.8 Dechra Veterinary Products
          • 14.8.1 Dechra Veterinary Products Company Profiles
          • 14.8.2 Dechra Veterinary Products Product Introduction
          • 14.8.3 Dechra Veterinary Products The Equine Pharmaceuticals and Supplements Sales, Revenue (2017-2021)
          • 14.8.4 Strategic initiatives
        • 14.9 Elanco Animal Health
          • 14.9.1 Elanco Animal Health Company Profiles
          • 14.9.2 Elanco Animal Health Product Introduction
          • 14.9.3 Elanco Animal Health The Equine Pharmaceuticals and Supplements Sales, Revenue (2017-2021)
          • 14.9.4 Strategic initiatives
        • 14.10 Norbrook Equine
          • 14.10.1 Norbrook Equine Company Profiles
          • 14.10.2 Norbrook Equine Product Introduction
          • 14.10.3 Norbrook Equine The Equine Pharmaceuticals and Supplements Sales, Revenue (2017-2021)
          • 14.10.4 Strategic initiatives
        • 14.11 Vetoquinol
        • 14.12 Ouro Fino Saude
        • 14.13 Protexin Healthcare
        • 14.14 Audevard

        15. Conclusion

        Summary

        The global economy is expected to expand 5.6% in 2021，global recovery is strong but uneven as many emerging market and developing economies continue to struggle with the COVID-19 pandemic, the world is unlikely to ever reach global herd immunity. However, the recovery in many countries is being held back by a resurgence of COVID-19 cases and lagging vaccination progress, as well as the withdrawal of policy support in some instances.

        The annual U.S. economic growth rate slipped to -3.5% in 2020, but grew at a yearly pace of more than 6% in the previous two quarters of 2021. The economy of continental Europe bounced back in the second quarter after having contracted in both the fourth quarter of 2020 and the first quarter of 2021, as the vaccinations accelerated, and governments eased restrictions. Among major economies, the annualized growth rate was 6.1% in Germany, 3.6% in France, 11.2% in Italy, and 11.7% in Spain. The especially rapid growth in Spain and Italy was attributed to a surge in consumer spending, likely the result of an easing of economic restrictions.

        Regional Economic Prospects: Growth in the East Asia and Pacific is projected to accelerate by 7.7% in 2021, Central Asia is forecast to grow by 3.9% this year, economic activity in the Middle East and North Africa is forecast to advance by 2.4%, South Asia is projected to expand by 6.8%.

        The global The Equine Pharmaceuticals and Supplements market size was USD XX billion in 2021. It is likely to progress at a CAGR of XX% during the forecast period of 2022-2027, according to XYZResearch analysis, The segment in The Equine Pharmaceuticals and Supplements market is estimated to reach a market value of USD XX billion by 2021 from an initial market value of USD XX billion in 2021. China market value in 2021 is about USD XX billion, and China The Equine Pharmaceuticals and Supplements production is XX (K Units). US market value in 2021 is about USD XX billion, and US The Equine Pharmaceuticals and Supplements production is XX (K Units). Europe market value in 2021 is about USD XX billion, and Europe The Equine Pharmaceuticals and Supplements production is XX (K Units).

        Regional Segmentation (Value; Revenue, USD Million, 2017 - 2027) of The Equine Pharmaceuticals and Supplements Market by XYZResearch Include
        USA
        Europe
        China
        Japan
        India
        Korea
        Southeast Asia
        Competitive Analysis; Who are the Major Players in The Equine Pharmaceuticals and Supplements Market?
        Boehringer Ingelheim
        Virbac
        Bayer Animal Health
        Merck Animal Health
        CEVA
        Zoetis
        Kyoritsu Seiyaku
        Dechra Veterinary Products
        Elanco Animal Health
        Norbrook Equine
        Vetoquinol
        Ouro Fino Saude
        Protexin Healthcare
        Audevard
        Major Type of The Equine Pharmaceuticals and Supplements Covered in XYZResearch report:
        Pharmaceuticals
        Supplements
        Application Segments Covered in XYZResearch Market
        Thoroughbred Horse
        Other Types of Horses

        For any other requirements, please feel free to contact us and we will provide you customized report.
        Buy now